Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.
06:45am, Monday, 03'rd Nov 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.
Top 10 High-Yield Dividend Stocks For November 2025
07:12am, Sunday, 02'nd Nov 2025
The November 2025 high-yield dividend watchlist highlights 10 stocks selected for quality, value, and attractive starting yields, aiming for a 12% CAGR. The watchlist's five-year CAGR is 14.49%, trail
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (Nov. 2025)
08:15am, Saturday, 01'st Nov 2025
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down
01:45pm, Thursday, 30'th Oct 2025
Merck tops Q3 earnings and revenue estimates on strong oncology, new drugs and animal health sales, while narrowing its 2025 revenue outlook.
Merck & Co., Inc. (MRK) Q3 2025 Earnings Call Transcript
01:36pm, Thursday, 30'th Oct 2025
Merck & Co., Inc. ( MRK ) Q3 2025 Earnings Call October 30, 2025 9:00 AM EDT Company Participants Peter Dannenbaum - Vice President of Investor Relations Robert Davis - Chairman, President & CEO Carol
My Top 10 High-Yield Picks For November 2025: One Yields 9%+
01:33pm, Thursday, 30'th Oct 2025
I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, a
Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit Outlook
12:24pm, Thursday, 30'th Oct 2025
Merck & Co., Inc. (NYSE:MRK) stock traded in a volatile session on Thursday following its third-quarter earnings report and updated fiscal 2025 outlook.
Merck Q3 financial results top estimates, company lowers revenue guidance
11:22am, Thursday, 30'th Oct 2025
Merck & Co Inc (NYSE:MRK, ETR:6MK) on Thursday reported third quarter 2025 earnings and revenue that surpassed Wall Street expectations, lifted by strong demand for its cancer immunotherapy Keytruda
Merck (MRK) Reports Q3 Earnings: What Key Metrics Have to Say
10:35am, Thursday, 30'th Oct 2025
The headline numbers for Merck (MRK) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge
09:20am, Thursday, 30'th Oct 2025
Merck published its financial results for Q3 2025 this morning. Strong demand for Winrevair from patients suffering from pulmonary arterial hypertension drove sales to $360 million in the third quarte
Merck (MRK) Q3 Earnings and Revenues Beat Estimates
08:46am, Thursday, 30'th Oct 2025
Merck (MRK) came out with quarterly earnings of $2.58 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $1.57 per share a year ago.
Merck Profit Rises on Strong Keytruda Demand
06:41am, Thursday, 30'th Oct 2025
Merck reported higher third-quarter profit and boosted its full-year outlook, as demand for its flagship Keytruda cancer drug continues to rise.
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit
06:38am, Thursday, 30'th Oct 2025
Merck reported third-quarter earnings and revenue that topped estimates in part due to strong demand for its cancer immunotherapy Keytruda, and narrowed its full-year profit outlook to reflect lower e
Merck posts higher third-quarter sales as Keytruda growth offsets drop from Gardasil
06:33am, Thursday, 30'th Oct 2025
Merck & Co on Thursday posted higher third quarter revenue as growth from its blockbuster cancer drug Keytruda offset falling sales from human papillomavirus vaccine Gardasil in China.
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results
06:30am, Thursday, 30'th Oct 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results.
